Your browser doesn't support javascript.
loading
[Yellow fever virus 17D neutralising antibodies in vaccinated Colombian people and unvaccinated ones having immunity against dengue]. / Anticuerpos neutralizantes contra el virus de la fiebre amarilla 17 D en colombianos vacunados y no vacunados con inmunidad a dengue.
Gómez, Sergio Y; Ocazionez, Raquel E.
Afiliação
  • Gómez SY; Centro de Investigaciones en Enfermedades Tropicales, Universidad Industrial de Santander, Bucaramanga, Colombia. sergioyebrailgm@yahoo.com
Rev Salud Publica (Bogota) ; 10(5): 796-807, 2008.
Article em Es | MEDLINE | ID: mdl-19360228
OBJECTIVE: Determining the frequency of yellow fever seroprotective antibody neutralising titres (YF-NT >or=1:10) in Colombians vaccinated with the 17 D virus and ascertaining the extent to which YF virus can be neutralised by dengue antibodies. MATERIALS AND METHODS: Serum samples were taken from 100 subjects who showed their vaccination record and from 116 residents in municipalities (Norte de Santander) affected by a wild YF outbreak in 2002-2003 who were reported to have been YF vaccinated. Sera from individuals with (n=61) and without (n=16) dengue antibodies who had never been YF vaccinated were included. All the sera were tested by 75 % YF plaque-reduction neutralization test. RESULTS: YF-NT titres >or=1:10 were founded in 90 % of subjects with vaccination recorded with minors variations in relation to age. In contrast, there was correlation between decrease of seroprotective YF-NT titres frequency and increase of immunization time (r=0.95; p=0.04). In residents in YF endemic area, YF-NT titres >or= 1.10 were founded in 92,6 % adults and 69 % children. YF 17 D virus was neutralized (52-100 %) by dengue sera more efficiently than non-dengue immune sera (p<0.001). CONCLUSIONS: Individuals immunised with YF vaccine 17 D could not be protected against YF: up to 31% children and 10 % adults. Dengue antibodies inhibited YF virus and its significance in terms of YF protection must be investigated.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Febre Amarela / Vacinação / Vacina contra Febre Amarela / Dengue / Antígenos Virais Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: America do sul / Colombia Idioma: Es Revista: Rev Salud Publica (Bogota) Assunto da revista: SAUDE PUBLICA Ano de publicação: 2008 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Colômbia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Febre Amarela / Vacinação / Vacina contra Febre Amarela / Dengue / Antígenos Virais Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: America do sul / Colombia Idioma: Es Revista: Rev Salud Publica (Bogota) Assunto da revista: SAUDE PUBLICA Ano de publicação: 2008 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Colômbia